午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频
<var id="lhmki"><font id="lhmki"></font></var>
<center id="lhmki"><label id="lhmki"></label></center>
BOC Sciences??? ?? ??? ?????.
?? ?:
BOC Sciences
??:
-16314854226;
???:
inquiry@bocsci.com
??:
United States
URL:
https://www.bocsci.com/
? ?? ?:
19654
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
?? ????
MAGE-12 (114-127)
MAGE-2 (127-136)
MAGE-1 (278-286)
MAGE-1 (62-70)
MAGE-1 (268-282)
MAGE-1 (222-231)
MAGE-1 (96-104)
MAGE-2 (157-166)
lymphocyte antigen 6 complex locus K (61-84)
Lengsin (270-279)
MAGE-12 (170-178)
MAGE-3 (111-125)
MART-1 (100-111)
MAPK/MAK/MRK overlapping kinase (352-360)
MAGE-2 (156-164)
MAPK/MAK/MRK overlapping kinase (32-40)
MAGE-6 (293-301)
MAGE-9 (223-231)
MAGE-1 (281-292)
MAGE-4 (156-163)
MAGE-3 (168-176)
MAGE-4 (230-239)
MAGE-3 (167-176)
MAGE-1 (90-104)
MAGE-3 (114-122)
MAGE-6 (168-176)
MAGE-3 (119-134)
MAGE-3 (281-295)
MAGE-4 (143-151)
MAGE-3 (191-205)
MAGE-6 (121-134)
MAGE-3 (143-151)
MAGE-3 (149-160)
MAGE-3 (111-126)
lymphocyte antigen 6 complex locus K (119-128)
L-lactate dehydrogenase A chain (254-265)
MART-1 (100-114)
MAGE-3 (243-258)
MAGE-3 (267-282)
MAGE-4 (169-177)
Melanoma-associated antigen C1 (1083-1091)
Melanoma-associated antigen C2 (42-50)
Melanoma antigen preferentially expressed in tumors (142-151)
Melanoma-associated antigen C1 (450-458)
Melanoma antigen preferentially expressed in tumors (300-309)
Melanoma-associated antigen C1 (959-968)
Melanoma-associated antigen C2 (307-315)
Melanoma-associated antigen C2 (43-57)
Melanoma-associated antigen C1 (137-149)
Melanoma antigen preferentially expressed in tumors (425-433)
MAGE-1 (230-238)
Melanoma antigen preferentially expressed in tumors (100-108)
melanoma-overexpressed antigen 1 (11-23)
Melanocyte protein Pmel 17 precursor (46-57)
MART-1 (91-110)
MART-1 (32-40)
Matrilysin (96-107)
Melanocyte protein Pmel 17 precursor (45-57)
Matrix protein 1 (229-237)
Melanoma antigen gp100 (280-288)
Melanocyte protein Pmel 17 precursor (40-57)
MART-1 (97-116)
Matrix protein 1 (27-35)
MART-1 (51-73)
MAGE-10 (290-298)
MAGE-12 (127-141)
MAGE-10 (254-262)
Melanoma-associated antigen C2 (336-344)
Melanoma antigen preferentially expressed in tumors (301-309)
Melanoma-associated antigen C1 (779-787)
Melanoma-associated antigen C2 (191-200)
MAGE-3 (112-120)
M-2420
310427-95-3
C70H91N15O27
LXW7
1313004-77-1
C29H48N12O12S2
Mammaglobin-A precursor (32-40)
LPGAT1 (262-270)
MAGE-1 (102-112)
MAGE-5 (5-12)
MAGE-3 (161-175)
MAGE-3 (113-121)
MAPK/MAK/MRK overlapping kinase (11-20)
MAGE-3 (97-105)
MAGE-6 (290-298)
Mammaglobin-A precursor (66-74)
MAGE-2 (212-220)
Mammaglobin-A precursor (83-92)
Mammaglobin-A precursor (2-10)
MARK Substrate
847991-34-8
C60H108N18O21
Mammaglobin-A (23-31)
MAGE-1 (289-298)
lymphocyte antigen 6 complex locus K (114-133)
Leukocyte Proteinase-3 (169-177)
MART-1 (1-20)
MART-1 (24-33(34))
MART-1 (100-116)
Melanocyte protein Pmel 17 precursor (44-57)
MART-1 (51-61)
MART 1 peptide (1-10)
Mammaglobin-A precursor (4-12)
L-Homocarnosine dihydrochloride
1807885-26-2
C10H17ClN4O3
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
Copyright 2019 ? ChemicalBook. All rights reserved